The tight correlation between radiotherapy and immune status has been confirmed and the prognostic value of SII in patients with BMs from EGFR-mutant lung adenocarcinoma who underwent brain radiotherapy remains elusive. This evidence concerns the gene EGFR and lung adenocarcinoma.